Meeting
2024 ASCO Genitourinary Cancers Symposium
Outcomes after primary retroperitoneal lymph node dissection in men with stage 2 non-seminomatous germ cell tumour: A multicenter retrospective cohort study.
Authors
Luca Antonelli
Luzerner Kantonsspital, Lucerne, Switzerland
Luca Antonelli , Axel Heidenreich , Aditya Bagrodia , Nicolas Branger , Timothy Clinton , Siamak Daneshmand , Hooman Djaladat , Robert James Hamilton , Matthew Ho , Wade J. Sexton , David Nicol , Nicola Nicolai , Kathleen Olson , James Porter , Nirmish Singla , Sean P. Stroup , Angelika Terbuch , Clint Cary , Christian Daniel Fankhauser
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Renal Cell Cancer; Adrenal, Penile, and Testicular Cancers
Track
Renal Cell Cancer,Adrenal Cancer,Penile Cancer,Testicular Cancer
Sub Track
Therapeutics
Citation
J Clin Oncol 42, 2024 (suppl 4; abstr 516)
DOI
10.1200/JCO.2024.42.4_suppl.516
Abstract #
516
Poster Bd #
L18
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Genitourinary Cancers Symposium
Viable germ cell tumor and teratoma can be distinguished from necrosis in postchemotherapy retroperitoneal lymph node dissection specimens by a combination of microRNA-371a-3p and 375-5p.
First Author: Tim Nestler
Poster
2024 ASCO Annual Meeting
Management of relapsed stage I nonseminomatous germ-cell tumor with retroperitoneal only relapse.
First Author: Ahmed Bilal Khalid
Poster
2024 ASCO Genitourinary Cancers Symposium
North American patterns of care in clinical stage I testicular cancer from SWOG S1823.
First Author: Antoine Morin Coulombe
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Adjuvant chemotherapy for older patients with stage II/III gastric cancer: A retrospective cohort study.
First Author: Yu-Hsuan Shih